Patient Education
When Eating Becomes Difficult: Students Rethink Cooking During Cancer Treatment
When cancer treatment makes eating difficult, small changes can make a difference. Discover how students from Croatia and North Macedonia are combi...
New Hope for Pancreatic Cancer as Daraxonrasib Nears EU Approval
Daraxonrasib has received a positive European recommendation for previously treated metastatic pancreatic cancer, following trial results showing l...
From the Other Side of the Laboratory Door
After undergoing pancreatic cancer treatment, Pamela stepped inside the laboratory through VOICE-Ireland. She reflects on learning the science behi...
When Every Month Matters, Innovation Must Reach Patients
Pamela reflects on the promise of daraxonrasib for people living with pancreatic cancer, the urgent need to turn scientific progress into timely an...
Clear Words Are Not Enough: What Patient-Friendly Communication Really Means
Clear words are only the beginning. Truly patient-friendly cancer communication considers timing, emotion, individual needs and understanding, help...
Strengthening Patient Voices at WECAN Academy 2026
DiCE advocates joined more than 100 patient leaders from 34 countries at WECAN Academy 2026, gaining new advocacy skills, sharing European initiati...
KI-COMPASS: Using AI to Transform Follow-Up Care After Gastroesophageal Cancer
KI-COMPASS is exploring how artificial intelligence, wearable technology and clinical data can personalise follow-up care after gastroesophageal ca...
New Patient-Led Survey Explores What Meaningful Cancer Support Really Looks Like
Every word matters. Take part in this patient-led survey exploring what meaningful cancer support truly looks like. Share your experience and help ...
What ASCO 2026 Means for People Living with Gastric Cancer
New treatment advances presented at ASCO 2026 are bringing fresh hope to people living with gastric cancer. Experts highlighted promising results f...
BREAKWATER Study Highlights the Growing Impact of Personalised Medicine in Colorectal Cancer
At this year’s ASCO Annual Meeting, researchers presented new results from the Phase III BREAKWATER trial, providing further evidence that a ...